Option Care Health Reports Modest Revenue Growth Amid Strategic Shifts — Option Care Health, Inc.

Event summary

Q2 2026 revenue up 1.9% YoY to $1.44 billion, GAAP net income rose 6.7% to $53.9 million.
Adjusted EBITDA increased 3.0% YoY to $117.5 million; adjusted diluted EPS up 9.8% to $0.45.
$150 million in share repurchases completed during the quarter.
Full-year revenue guidance narrowed slightly to $5.675–$5.775 billion, with adjusted EBITDA targeted at $480–$495 million.

The big picture

Option Care Health's Q2 results reflect steady operational execution, but revenue growth remains modest. The company is positioning itself for long-term sustainability in the home infusion services market, where scale and clinical expertise are key differentiators. With a focus on strategic initiatives, Option Care Health aims to navigate industry shifts while maintaining profitability.

What we're watching

Revenue Growth Dynamics: Whether Option Care Health can sustain low-to-mid single-digit sequential revenue growth amid competitive pressures.
Operational Efficiency: The pace at which adjusted EBITDA margins improve, given mid-single-digit sequential growth expectations.
Capital Allocation: How the $150 million share repurchase impacts liquidity and future strategic investments.